April 06, 2026 9:50am
OptimumBank Holdings (NYSE American: OPHC) announced it will host its Annual Shareholder Meeting and Investor Day on April 28, 2026, at its Fort Lauderdale headquarters, with a virtual webcast option beginning at 10:00 a.m. ET, and shareholders of record as of March 9, 2026 eligible to vote. Interested participants may attend in person or register … Continue reading “QualityStocksNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) Sets April 28 Annual Meeting And Investor Day”
April 06, 2026 9:40am
Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced a joint development, manufacturing and licensing agreement with Oncotelic Therapeutics (OTCQB: OTLC) to co-develop AI-enhanced, GMP-compliant robotic systems for pharmaceutical manufacturing and laboratory automation. The collaboration combines TechForce’s robotics engineering with Oncotelic’s AI-driven pharmaceutical technologies to target improved efficiency, compliance and scalability in biopharma production, … Continue reading “QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Enters Robotics And AI Biopharma Partnership With Oncotelic Therapeutics (OTCQB: OTLC)”
April 06, 2026 9:30am
ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional purchase order from an Israeli defense entity for its DefendAir counter-unmanned aerial systems, representing a follow-on order under an existing direct contract as demand rises amid escalating drone threats in modern conflicts. The company said its multi-layered, soft-kill DefendAir system uses patented net-launching technology to … Continue reading “QualityStocksNewsBreaks – InvestorNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Follow-On DefendAir Counter-Drone Order From Israeli Defense Entity”
April 06, 2026 9:20am
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a letter from the FDA Office of Generic Drugs indicating only minor formatting comments on the proposed label for its preservative-free ketamine product, with a final label submission expected this month and potential approval of its Abbreviated New Drug Application anticipated in Summer 2026 pending final review. … Continue reading “QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application”
April 06, 2026 9:10am
Frontieras North America held a groundbreaking ceremony in Point Pleasant, West Virginia, to mark the start of construction on its Mason County Plant, the company’s first commercial-scale facility utilizing its proprietary FASForm coal processing technology. Executives and local officials emphasized the project’s role in transforming coal into higher-value outputs, including ultra-low sulfur diesel, fertilizers and … Continue reading “QualityStocksNewsBreaks – Frontieras North America Marks Mason County Plant Groundbreaking With Ceremony in West Virginia”
April 06, 2026 9:00am
Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel T. Bradley will present and exhibit the Company’s DataValue(R), DataScore(R), Data Vault Bank(R) AI Agent and Information Data Exchange(R) technologies at XRP Tokyo 2026 on April 7, 2026, highlighting its AI-powered infrastructure for real-world asset tokenization as it targets Japan’s rapidly expanding, regulation-friendly market and broader APAC … Continue reading “QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Showcase RWA Tokenization Technologies at XRP Tokyo 2026”
April 02, 2026 11:07am
Xeriant (OTCQB: XERI) announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for its patent covering a proprietary multilayered fire-resistant composite and manufacturing method, marking a key milestone for its DUREVER(TM) materials platform. The technology, featured in NEXBOARD(TM) composite wallboard, is advancing toward certification testing and is designed to deliver enhanced fire resistance, strength and sustainability across multiple … Continue reading “QualityStocksNewsBreaks – Xeriant, Inc. (OTCQB: XERI) Notice Of Allowance For Fire-Resistant Composite Patent “
April 02, 2026 10:57am
Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse … Continue reading “QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy “
April 02, 2026 10:43am
This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported a series of milestones advancing the scale and commercial potential of its Saskatchewan-based Natural Hydrogen portfolio, including successful drilling at the Bracken Well, completion of a high-resolution 3D seismic survey at the Lawson Discovery … Continue reading “QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Saskatchewan Natural Hydrogen Portfolio with New Discovery Milestones “
April 02, 2026 10:32am
This article has been disseminated on behalf of NurExone Biologic and may include paid advertising. NurExone Biologic (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) announced it received first place in the Healthcare category at the BOLD Awards VII Gala held March 27, 2026, in Barcelona, recognizing its leadership in exosome-based therapies for central nervous system injuries, and also provided a corporate update highlighting its selection by a panel of … Continue reading “QualityStocksNewsBreaks – NurExone Biologic Inc. (TSX.V: NRX) (OTCQB: NRXBF) (FSE: J90) Wins BOLD Awards VII Healthcare Honor, Engages IBN For Investor Outreach “
April 02, 2026 10:00am
This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced the release of its latest investor presentation, outlining strategy, technology development and commercial growth initiatives, including expanded global distribution efforts for its Overwatch solution. The platform delivers advanced targeting, geolocation … Continue reading “QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Releases Updated Investor Presentation Highlighting Growth Strategy”
April 02, 2026 9:50am
Oncotelic Therapeutics (OTCQB: OTLC) announced a strategic partnership with TechForce Robotics to advance commercialization of its PDAOAI-enabled, GMP-compliant robotics platform designed for pharmaceutical manufacturing and regulated environments. The integrated system combines Oncotelic’s proprietary AI capabilities with TechForce’s robotics and manufacturing expertise to enable automated material handling, real-time monitoring and compliance workflows, with scalability for broader … Continue reading “QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics to Advance AI-Enabled GMP Automation Platform”
April 02, 2026 9:30am
This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced a strategic investment of $250,000 in Antaris following the first close of the company’s $28 million Series A financing, gaining exposure to an emerging leader in AI-driven space mission … Continue reading “QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Invests $250,000 In AI-Driven Space Software Company Antaris”
April 02, 2026 9:20am
American Fusion (OTC: AMFN) reported it is in the final stages of securing multi-year supply agreements with a U.S.-based subsidiary of a global industrial organization for helium-3 and deuterium, key fuels for its Texatron aneutronic fusion system. The proposed framework is expected to strengthen the company’s long-term commercialization strategy by establishing reliable access to critical … Continue reading “QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Nears Fuel Supply Agreements Supporting Aneutronic Fusion Commercialization”
April 06, 2026 11:15am
American Fusion (OTC: AMFN), an advanced energy platform company focused on the development and commercialization of an advanced fusion energy technology, recently highlighted its participation in multiple industry events as part of a broader effort to remain connected to technical research and power-system engineering developments (https://ibn.fm/5C8bp). In March, company representatives attended two international technical gatherings. … Continue reading “American Fusion(TM) Inc. (AMFN) Expands Industry Engagement, Appoints New CFO to Strengthen Capital Markets Strategy”
April 06, 2026 10:30am
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Gold’s latest pullback has done little to weaken the deeper investment case for the yellow metal. As recent commentary observes, gold’s importance lies not only in price momentum but in its unusual utility as a store of value, a reserve … Continue reading “Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Position in Growing Global Gold Cycle”
April 06, 2026 9:45am
Safe Pro Group (NASDAQ: SPAI), a company that develops security, defense, and situational awareness solutions, recently announced that the company is adding Brian Mack to the Strategic Advisory Board (https://ibn.fm/1VI8x). Mack, who is a retired U.S. Army Officer and a former Anduril Senior Business Development Director, has a proven track record in defense capture, growth … Continue reading “Safe Pro Group Inc. (NASDAQ: SPAI) Adds Brian Mack to the Company’s Strategic Advisory Board”
April 06, 2026 9:00am
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology innovator commercializing AI-powered voice analytics for real-time drug and alcohol impairment detection, is moving toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus … Continue reading “MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets South American Mining Sector as Voice-Based Drug and Alcohol Impairment Screening Platform Moves Toward Commercial Deployment”
April 02, 2026 9:45am
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced defense systems. As demand accelerates and supply remains heavily concentrated … Continue reading “Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges”
April 02, 2026 9:00am
Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. As demand for organic food continues to grow across North America, attention is increasingly turning to the upstream inputs required to sustain that expansion. One of the most difficult inputs to scale has been phosphate fertilizer that complies … Continue reading “Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Targets Supply Gap in Fertilizer for Expanding Organic Food Market”
April 01, 2026 11:15am
The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for … Continue reading “Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication”
April 01, 2026 10:30am
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Securing reliable supplies of specialized rare earth elements is becoming increasingly important as demand rises across defense, energy and advanced manufacturing sectors. With this in mind, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently announced that it is … Continue reading “Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Expands Strategy for Critical Magnet Materials Supply”
April 01, 2026 9:00am
Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, reported strong revenue growth and improving loan economics in its recently reported fourth-quarter 2025 results, highlighting a strategy that combines digital mortgage origination with new fee-based real-estate finance products. The fintech lender posted net revenue of $2.5 million … Continue reading “Beeline Holdings Inc. (NASDAQ: BLNE) Reports 127% Revenue Growth and Key Milestones Achieved in Q4 2025, Detailing Strategic Priorities for 2026”
March 31, 2026 11:15am
LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing … Continue reading “LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes”
March 31, 2026 10:30am
Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. In today’s rapidly evolving battlefield, drones have become one of the most influential tools in modern warfare, reshaping how militaries gather intelligence, navigate contested environments, and execute operations. Yet as drone usage expands, so does the threat of GPS … Continue reading “GPS-Denied Navigation Isn’t Just a Problem for the Future, It’s Happening Right Now”
March 31, 2026 9:45am
A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development that highlights both the potential of … Continue reading “Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition”
March 31, 2026 9:00am
Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators. At the core of its … Continue reading “Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’”
March 30, 2026 11:15am
Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, continues to demonstrate why and how gold is a viable investment in 2026, particularly compared to investment alternatives. As a company … Continue reading “ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Seen as an Easy Way to Capitalize on Gold’s Rare Affordable Price”